Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Summary
Martin Shkreli, who was banned for life from the pharmaceutical industry in 2022 for illegal drug pricing and fraud, has allegedly broken this ban by trading pharmaceutical stocks and discussing the industry in livestreams. The Federal Trade Commission (FTC) and seven states have asked a judge to hold him in contempt and impose penalties for these actions.Key Facts
- Shkreli was banned for life from the pharmaceutical industry due to his illegal price hike and fraud involving the drug Daraprim.
- The ban forbids him from owning pharmaceutical stocks or making public statements that influence pharmaceutical companies.
- The FTC and seven states (including New York, California, and Illinois) say Shkreli repeatedly violated this ban through stock trading and social media livestreams.
- They want Shkreli to sell all pharmaceutical stocks and pay fines equal to his trading profits.
- The FTC seeks strict penalties for any future violations, including fines and possible jail time.
- Shkreli publicly admitted to trading pharmaceutical stocks and giving stock advice during livestreams.
- His violations happened in multiple phases from 2022 to 2026, including trading challenges and short selling biotech stocks.
- Shkreli responded on social media, expressing surprise and criticizing the FTC’s actions.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
